AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M
The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
LocalNews Oct 22, 2022 0 6
LocalNews Nov 21, 2022 0 6
LocalNews Nov 29, 2022 0 6
LocalNews Apr 4, 2023 0 6
LocalNews Nov 16, 2022 0 5
LocalNews Sep 27, 2023 0 247
The ultra-green project on Capitol Hill sold for more than $633,000 per unit.
LocalNews Apr 29, 2023 0 183
The challenge of recruiting and retaining talent in the post-Covid world continues...
LocalNews Apr 28, 2023 0 36
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for...
LocalNews Apr 25, 2023 0 49
We crunch the numbers on the country’s most valuable startups
LocalNews Apr 21, 2023 0 49
Automation and expansion go hand in hand